CompletedNot applicableNCT00504023

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Studying Vulvar carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Memorial Sloan Kettering Cancer Center
Principal Investigator
Dennis S. Chi, MD, FACOG, FACS
Memorial Sloan Kettering Cancer Center
Intervention
imiquimod(drug)
Enrollment
8 enrolled
Eligibility
18 years · FEMALE
Timeline
20072018

Study locations (2)

Collaborators

National Cancer Institute (NCI) · Ohio State University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00504023 on ClinicalTrials.gov

Other trials for Vulvar carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Vulvar carcinoma

← Back to all trials